You searched for Antibody candidate - Page 54 of 69

News and Trends 7 Sep 2022

OncoResponse and Regeneron to evaluate drug combo for patients with advanced cancer

…in a separate biology cohort. About OR2805 OR2805 is a fully human antibody discovered using B cells derived from an elite responder to checkpoint inhibitor (CPI) therapy. This antibody binds…

September 7, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 24 Mar 2025

First-ever RIPTAC enters clinic: all you need to know about this new cancer approach

…antibody-drug conjugates (ADCs), which are composed of a monoclonal antibody, a cytotoxic drug – typically a chemotherapy – and a linker. But unlike ADCs, which deliver the drug specifically to…

March 24, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 12 Aug 2022

argenx secures European Commission approval for generalized myasthenia gravis treatment

…generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. The approval is applicable to all 27 European Union (EU) Member States plus Iceland, Norway and Liechtenstein. argenx said…

August 12, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 16 May 2023

LabGenius looks to create molecules with huge increase in tumor killing ability

LabGenius, which uses machine learning (ML) for antibody discovery, has presented data in a poster presentation at the Protein Engineering and Biotherapeutics (PEGS) annual meeting. The data were from LabGenius’…

May 16, 2023 - 3 minutesmins - By Jim Cornall

KBI Biopharma microbial CLD 16JUL2024 article labiotech main illustration

How a microbial expression update is driving biotech innovation

…to prepare for future applications, including antibody fragments and therapeutic peptides. While microbial protein production systems present cost-efficient alternatives to insect or mammalian cells, the commonly used E. coli strains…

July 16, 2024 - 7 minutesmins - By Ute Boronowsky

News and Trends 25 Nov 2021

Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines

…the European Commission gave its stamp of approval to two antibody treatments for Covid-19: regdanvimab from the South Korean firm Celltrion Healthcare, and a blend of two antibodies called casirivimab…

November 25, 2021 - 6 minutesmins - By Victor Kotsev

Best in Biotech 26 Jun 2023

Five animal health companies you should know about

…Parvovirus Monoclonal Antibody, which targets canine parvovirus (CPV); and Seresto for Dogs, for preventing ticks and fleas. Meanwhile, for farm animals, the company supports the prevention, control and treatment of…

June 26, 2023 - 6 minutesmins - By Willow Shah-Neville

More News! 22 Nov 2018

First Drug for Rare Inflammation Syndrome Approved by FDA

…antibody drug, emapalumab, is approved to treat primary hemophagocytic lymphohistiocytosis. This condition is a rare, often fatal syndrome in which the immune system produces too many activated immune cells, as…

November 22, 2018 - 2 minutesmins - By Jonathan Smith

The crucial role of GS-CHO innovation in biopharmaceutical progress

…cells, a cellular mechanism called antibody dependent cell-mediated cytotoxicity (ADCC) can enhance an antibody’s ability to destroy cancer cells. “We know that antibodies which lack the core N-glycan fucose sugar…

September 3, 2024 - 8 minutesmins - By Alexander Burik

derek jones babraham bioscience technologies incubator

Interview 20 Sep 2017

A Peek Inside Europe’s Best Incubator: A Conversation with Babraham’s Chief Executive

…field, Cambridge Antibody Technology, grew out of Babraham. Bicycle Therapeutics, Kymab, and Crescendo Biologics all count with former CAT employees and are now following in its footsteps to improve antibody-based…

September 20, 2017 - 9 minutesmins - By Evelyn Warner

Isogenica Maverick Therapeutics llama antibodies cancer 1

News and Trends 7 Feb 2017

British Synbio’s Llama Antibodies recruited for Cancer T-Cell Therapy

Isogenica has licensed its synthetic llama antibody library to Maverick Therapeutics, which develops cancer T-cell therapies designed to reduce side effects. Isogenica is a synthetic biology company near Cambridge that…

February 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Jan 2017

This British Biotech is buying its way into the Crowded NASH Space

…the company is in-licensing a fully human monoclonal antibody from Novimmune, in Switzerland. No details on the size of the deal have been disclosed. The drug candidate in question, NI-1201,…

January 4, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

OncoResponse and Regeneron to evaluate drug combo for patients with advanced cancer

First-ever RIPTAC enters clinic: all you need to know about this new cancer approach

argenx secures European Commission approval for generalized myasthenia gravis treatment

LabGenius looks to create molecules with huge increase in tumor killing ability

How a microbial expression update is driving biotech innovation

Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines

Five animal health companies you should know about

First Drug for Rare Inflammation Syndrome Approved by FDA

The crucial role of GS-CHO innovation in biopharmaceutical progress

A Peek Inside Europe’s Best Incubator: A Conversation with Babraham’s Chief Executive

British Synbio’s Llama Antibodies recruited for Cancer T-Cell Therapy

This British Biotech is buying its way into the Crowded NASH Space

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!